Aptar Digital Health Announces FDA 510(k) Clearance for HeroTracker® Sense, a Connected Add-On Device for Metered-Dose Inhalers
Aptar Digital Health, a global leader in digital health solutions enhancing the patient experience, today announced that the U.S Food and Drug Administration (FDA) has granted 510(k) clearance for HeroTracker® Sense as a Class II medical device. This milestone recognizes HeroTracker® Sense - a Bluetooth-enabled sensor - as an innovative connected add-on for pressurized Metered Dose Inhalers (pMDIs), transforming traditional inhalers into smart, data-driven devices for patients and healthcare professionals.
Aptar Named Among Top 100 of the ‘World’s Top Companies for Women 2025’ by Forbes
AptarGroup, Inc. (
NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that it has been named a World’s Top Companies for Women 2025 by Forbes for the fifth consecutive year (formerly World’s Top Female Friendly Companies). Aptar is ranked 72 out of the 400 companies included on the list by Forbes and their partner Statista.
Aptar Increases Quarterly Dividend by Nearly 7% Signaling Continued Momentum and Long-Term Strength
AptarGroup, Inc. (
NYSE:ATR), a global leader in drug delivery, consumer product dosing, dispensing and protection technologies, today declared a quarterly cash dividend of $0.48 per share, an almost 7% increase from the previous dividend amount, bringing the new annualized dividend to $1.92 per share. The payment date is November 13, 2025, to stockholders of record as of October 23, 2025.
Aptar Announces 2025 Investor Day
AptarGroup, Inc. (
NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, will host an Investor Day on Tuesday, September 9, 2025. The event will begin at 9:00 a.m. EDT.
Aptar Reports Second Quarter 2025 Results
AptarGroup, Inc. (
NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today reported the following second quarter results for the period ended June 30, 2025, as compared to the corresponding period of the last fiscal year.
Aptar Declares Quarterly Dividend
AptarGroup, Inc. (
NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today declared a quarterly cash dividend of $0.45 per share. The payment date is August 14, 2025 to stockholders of record as of July 24, 2025.
Aptar Named One of the World’s Most Sustainable Companies by TIME for Second Consecutive Year
AptarGroup, Inc. (
NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that it has been named one of the World’s Most Sustainable Companies 2025 by TIME. Aptar is ranked 244 out of 500 global companies evaluated by TIME and its partner Statista.
Aptar to Participate in Upcoming Investor Conferences
AptarGroup, Inc. (
NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that it will present at two upcoming investor conferences:
Aptar Releases 2024 Corporate Sustainability Report
AptarGroup, Inc. (
NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today released its 2024 Corporate Sustainability Report entitled Progress Takes Shape. Aptar’s report highlights key milestones of its global sustainability strategy across the company’s global operations focused on three key pillars:
Aptar Reports First Quarter 2025 Results
AptarGroup, Inc. (
NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today reported the following first quarter results for the period ended March 31, 2025, as compared to the corresponding period of the last fiscal year.
Aptar Declares Quarterly Dividend
AptarGroup, Inc. (
NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today declared a quarterly cash dividend of $0.45 per share. The payment date is May 22, 2025, to stockholders of record as of May 1, 2025.
